Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Marcin ChwistekMD
Hematopoietic Cell Transplantation and Cellular Therapy · Philadelphia, PA 19111
NPI: 1548366321
41
🟠 Elevated
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,063
Total Claims
$448K
Drug Cost
186
Beneficiaries
$2,408
Cost/Patient
Risk Score Breakdown 41/100
Score components are additive. Read full methodology
Peer Comparison vs. 134 Hematopoietic Cell Transplantation and Cellular Therapy providers
+1784%
Opioid rate vs peers
62.5% vs 3.3% avg
-87%
Cost per patient vs peers
$2,408 vs $19K avg
+21%
Brand preference vs peers
17.3% vs 14.3% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 1,784% above the average for Hematopoietic Cell Transplantation and Cellular Therapy providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
62.5%
Opioid Rate
1,289
Opioid Claims
$395K
Opioid Cost
41.9%
Long-Acting Rate
This provider's opioid prescribing rate of 62.5% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 357 claims · $372K
Generic: 1,706 claims · $76K
Patient Profile
67
Avg Age
55%
Female
2.54
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About